Developmental Funds
- Institution
- UNIVERSITY OF MARYLAND BALTIMORE, MD
- Principal investigator
- Taofeek K Owonikoko
- Funding
- $129K
- Duration
- 2008–2026
Moonbase score
Still being scored
Abstract
4.0 Abstract: Developmental Funds Developmental funds support the University of Maryland Marlene and Stewart Greenebaum Comprehensive Cancer Center's (UMGCCC's) mission by facilitating recruitment of new faculty in areas of strategic need and by supporting pilot studies necessary to develop research so that it can compete for extramural funding. UMGCCC has also used Cancer Center Support Grant (CCSG) pilot funds to support didactic clinical research training for new faculty. In the last funding cycle, $701,806 in CCSG funds were invested in faculty recruitment for the Population Science Program. In contrast, $1.8 million in pilot research funds ($373,832 from CCSG) were allocated in the last cycle. These pilot grants resulted in $14.2 million of new extramural funding. In addition, UMGCCC invested more than $11.3 million in funds to recruit new basic and clinical research faculty. This funding was leveraged by an additional $24.1 million in departmental and institutional funds to support basic science and clinical recruits who are members of UMGCCC. These recruits have significantly enhanced all five UMGCCC research programs. In the current application, $179,000 in CCSG developmental funds are requested to support UMGCCC investigators' pilot projects and provide preliminary data for future external funding of novel projects. Because of a need identified as part of our strategic planning process, $148,093 per year in CCSG developmental funding is requested to support faculty development in areas of strategic need. These funds will be used to help newly recruited clinical research faculty complete certificate training in clinical research. UMGCCC is committed to enhancing the clinical research capabilities of new faculty in multiple cancer disciplines.
LOADING MOONBASE SCORE
Questions for UNIVERSITY OF MARYLAND BALTIMORE
Answered by the team behind this research.
No questions yet. Sign in to ask the first one
Related grants
Same researchers, same institution, same topic, scored first.
- NIH · University of Maryland Baltimore64
Targeting polo-like kinase 1 (PLK1) for treatment of small cell lung cancer
Taofeek K Owonikoko · $648K · 2022–2027
- NIH · University of Maryland BaltimoreNot yet scored
Advancing Oncologic Research Communities in Health Equity (ARCH) K12 Program
Stuart S Martin · $54K · 2025–2030
- NIH · University of Maryland BaltimoreNot yet scored
UNIVERSITY OF MARYLAND GREENEBAUM CANCER CENTERSUPPORT GRANT
Taofeek K Owonikoko · $2.3M · 2008–2026